Discontinuation report TEVA-HYDROMORPHONE

Last updated on 2020-02-13 History
Report ID 106158
Drug Identification Number 02319403
Brand name TEVA-HYDROMORPHONE
Common or Proper name HYDROMORPHONE
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N02AA
ATC description OPIOIDS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-08-31
Remaining supply date 2017-08-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-02-13 French Compare
v1 2020-02-13 English Compare

Showing 1 to 2 of 2